• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-576-3p、miR-613、NDRG2 和 YKL40 在结直肠癌患者中的临床潜力。

Clinical Potentials of miR-576-3p, miR-613, NDRG2 and YKL40 in Colorectal Cancer Patients.

机构信息

Department of Biochemistry, Faculty of Science, Helwan University, Cairo, Egypt.

Department of Environmental & Occupational Medicine, National Research Centre, Cairo, Egypt.

出版信息

Asian Pac J Cancer Prev. 2020 Jun 1;21(6):1689-1695. doi: 10.31557/APJCP.2020.21.6.1689.

DOI:10.31557/APJCP.2020.21.6.1689
PMID:32592365
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7568881/
Abstract

INTRODUCTION

Colorectal cancer (CRC) is the most common type of gastrointestinal tract cancers. This investigation aim was to assess the expression of miR-576-3p and miR-613 in CRC patients in addition to NDRG2 and YKL40 serum levels determination to decide their diagnostic and prognostic significance.

METHODS

Sixty early diagnosed CRC patients prior to any treatment in addition to twelve healthy subjects were enrolled in this study. Blood samples were taken from subjects and allowed for clotting and centrifugation, then the collected sera were stored at -80ºC till it were used for detection of our molecular biomarkers. The mature miRNAs expressions (miR-576-3p and miR-613) were detected in serum by qRT-PCR, while NDRG2 and YKL40 serum levels were determined by ELISA. In addition, the correlation of the measured parameters with the clinicopathological data of the patients was investigated.

RESULTS

The study results showed that both miRNA-576-3p and miRNA-613 were down-regulated in CRC patients with fold change 0.33, 0.36; respectively. A significant positive correlation was observed between miR-576-3p and miR-613 (r = 0.75, p < 0.001). NDRG2 serum levels were decreased in patients compared to the control group but the decrease wasn't statistically significant. On the other hand, it was observed that YKL40 serum level was significantly increased in CRC patients compared to control (p-value < 0.001). Furthermore, YKL40 showed a very high diagnostic value (AUC = 0.97, specificity = 91.7%, sensitivity = 96%, p-value = 0.0001).

CONCLUSION

The observations of this investigation concluded that, the expressions of miR-576-3p and miR-613 in addition to YKL40 serum levels determinations may help in the diagnosis of CRC.

摘要

简介

结直肠癌(CRC)是最常见的胃肠道癌症类型。本研究旨在评估 miR-576-3p 和 miR-613 在 CRC 患者中的表达,以及 NDRG2 和 YKL40 血清水平的测定,以确定其诊断和预后意义。

方法

本研究纳入了 60 例早期诊断的 CRC 患者(未经任何治疗)和 12 例健康对照者。采集受试者血液样本,待血液凝固和离心后,收集血清并储存在-80°C,直至用于检测我们的分子生物标志物。通过 qRT-PCR 检测血清中成熟 miRNA(miR-576-3p 和 miR-613)的表达,通过 ELISA 检测 NDRG2 和 YKL40 血清水平。此外,还研究了所测参数与患者临床病理数据的相关性。

结果

研究结果显示,miR-576-3p 和 miR-613 在 CRC 患者中均下调, fold change 分别为 0.33 和 0.36。miR-576-3p 和 miR-613 之间存在显著正相关(r = 0.75,p < 0.001)。与对照组相比,NDRG2 血清水平在患者中降低,但差异无统计学意义。另一方面,观察到 YKL40 血清水平在 CRC 患者中显著升高(p 值<0.001)。此外,YKL40 具有非常高的诊断价值(AUC = 0.97,特异性 = 91.7%,灵敏度 = 96%,p 值 = 0.0001)。

结论

本研究观察到,miR-576-3p 和 miR-613 的表达以及 YKL40 血清水平的测定可能有助于 CRC 的诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/395e/7568881/e1f48078c4b4/APJCP-21-1689-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/395e/7568881/6c6dc92df140/APJCP-21-1689-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/395e/7568881/e1f48078c4b4/APJCP-21-1689-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/395e/7568881/6c6dc92df140/APJCP-21-1689-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/395e/7568881/e1f48078c4b4/APJCP-21-1689-g002.jpg

相似文献

1
Clinical Potentials of miR-576-3p, miR-613, NDRG2 and YKL40 in Colorectal Cancer Patients.miR-576-3p、miR-613、NDRG2 和 YKL40 在结直肠癌患者中的临床潜力。
Asian Pac J Cancer Prev. 2020 Jun 1;21(6):1689-1695. doi: 10.31557/APJCP.2020.21.6.1689.
2
Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.循环 microRNA-1290 作为人类结直肠癌的新型诊断和预后生物标志物。
Ann Oncol. 2016 Oct;27(10):1879-86. doi: 10.1093/annonc/mdw279. Epub 2016 Aug 8.
3
Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.miR-143-3p 和 -424-5p 在结直肠癌中的表达水平及其临床意义。
Cancer Biomark. 2019;24(3):291-297. doi: 10.3233/CBM-182171.
4
Downregulation of Serum miR-133b and miR-206 Associate with Clinical Outcomes of Progression as Monitoring Biomarkers for Metastasis Colorectal Cancer Patients.血清 miR-133b 和 miR-206 下调与转移性结直肠癌患者进展的临床结局相关,可作为监测的生物标志物。
Microrna. 2024;13(1):56-62. doi: 10.2174/0122115366266024240101075745.
5
Validation of miR-1228-3p as Housekeeping for MicroRNA Analysis in Liquid Biopsies from Colorectal Cancer Patients.验证 miR-1228-3p 作为结直肠癌患者液体活检中 miRNA 分析的管家基因。
Biomolecules. 2019 Dec 20;10(1):16. doi: 10.3390/biom10010016.
6
Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.血清miR-139-3p作为结直肠癌非侵入性生物标志物的鉴定。
Oncotarget. 2017 Apr 18;8(16):27393-27400. doi: 10.18632/oncotarget.16171.
7
Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.miRNA-210、miRNA-21 和 miRNA-126 作为结直肠癌诊断生物标志物的作用:HIF-1α-VEGF 信号通路的影响。
Mol Cell Biochem. 2019 Apr;454(1-2):177-189. doi: 10.1007/s11010-018-3462-1. Epub 2018 Oct 24.
8
A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.血清中六种循环 miRNA 标志物的检测 panel 及其在结直肠癌诊断中的潜在价值。
Life Sci. 2020 Oct 1;258:118226. doi: 10.1016/j.lfs.2020.118226. Epub 2020 Aug 6.
9
Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression.结直肠癌来源的外泌体 miR-106b-3p 通过下调 DLC-1 表达促进转移。
Clin Sci (Lond). 2020 Feb 28;134(4):419-434. doi: 10.1042/CS20191087.
10
Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.血清 miR-497 表达在结直肠癌中的临床反应及预后意义。
Cancer Biomark. 2019;25(1):11-18. doi: 10.3233/CBM-181902.

引用本文的文献

1
Copper in the colorectal cancer microenvironment: pioneering a new era of cuproptosis-based therapy.结直肠癌微环境中的铜:开创基于铜死亡疗法的新时代。
Front Oncol. 2025 Jan 9;14:1522919. doi: 10.3389/fonc.2024.1522919. eCollection 2024.
2
Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer.几丁质酶 3 样蛋白 1 在炎症性疾病和癌症发病机制中的意义。
Exp Mol Med. 2024 Feb;56(1):1-18. doi: 10.1038/s12276-023-01131-9. Epub 2024 Jan 4.
3
Potential Roles and Future Perspectives of Chitinase 3-like 1 in Macrophage Polarization and the Development of Diseases.

本文引用的文献

1
Retraction notice to "miR-613 inhibits proliferation and invasion of breast cancer cell via VEGFA" [Biochem. Biophys. Res. Commun. 478/1 (2016) 274-278].对“miR-613通过VEGFA抑制乳腺癌细胞的增殖和侵袭”[《生物化学与生物物理研究通讯》478/1 (2016) 274 - 278]的撤稿通知。
Biochem Biophys Res Commun. 2019 Aug 6;515(4):734. doi: 10.1016/j.bbrc.2018.11.192.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
几丁质酶 3 样蛋白 1 在巨噬细胞极化及疾病发生发展中的潜在作用和未来展望。
Int J Mol Sci. 2023 Nov 9;24(22):16149. doi: 10.3390/ijms242216149.
4
The siRNA-mediated knockdown of SNHG4 efficiently induced pro-apoptotic signaling and suppressed metastasis in SW1116 colorectal cancer cell line.SNHG4 的 siRNA 介导的敲低有效地诱导了促凋亡信号,并抑制了 SW1116 结直肠癌细胞系的转移。
Mol Biol Rep. 2023 Nov;50(11):8995-9006. doi: 10.1007/s11033-023-08742-5. Epub 2023 Sep 16.
5
Detection of Chitinase 3-Like 1 in Symptomatic Primary Care Patient Faecal Samples is Not a Reliable Biomarker of Colonic Lesions.在有症状的初级保健患者粪便样本中检测几丁质酶 3 样蛋白 1 不是结直肠病变的可靠生物标志物。
Asian Pac J Cancer Prev. 2023 Jul 1;24(7):2289-2293. doi: 10.31557/APJCP.2023.24.7.2289.
6
MicroRNA Biomarkers as Promising Tools for Early Colorectal Cancer Screening-A Comprehensive Review.MicroRNA 生物标志物作为早期结直肠癌筛查的有前途的工具——全面综述。
Int J Mol Sci. 2023 Jul 3;24(13):11023. doi: 10.3390/ijms241311023.
7
Proteome Analysis of the Antiproliferative Activity of the Novel Chitooligosaccharide-Gallic Acid Conjugate against the SW620 Colon Cancer Cell Line.新型壳寡糖-没食子酸共轭物对SW620结肠癌细胞系抗增殖活性的蛋白质组学分析
Biomedicines. 2023 Jun 10;11(6):1683. doi: 10.3390/biomedicines11061683.
8
Tumor Suppressor miR-613 Alleviates Non-Small Cell Lung Cancer Cell via Repressing M2 Macrophage Polarization.肿瘤抑制因子miR-613通过抑制M2巨噬细胞极化减轻非小细胞肺癌细胞
J Oncol. 2023 Feb 16;2023:2311231. doi: 10.1155/2023/2311231. eCollection 2023.
9
Biomarkers to Detect Early-Stage Colorectal Cancer.用于检测早期结直肠癌的生物标志物。
Biomedicines. 2022 Jan 25;10(2):255. doi: 10.3390/biomedicines10020255.
10
Identification of Target PTEN-Based miR-425 and miR-576 as Potential Diagnostic and Immunotherapeutic Biomarkers of Colorectal Cancer With Liver Metastasis.基于靶标PTEN的miR-425和miR-576作为结直肠癌肝转移潜在诊断和免疫治疗生物标志物的鉴定。
Front Oncol. 2021 Aug 19;11:657984. doi: 10.3389/fonc.2021.657984. eCollection 2021.
miRNA expression profiles of premalignant and malignant arsenic-induced skin lesions.
砷诱导的癌前和恶性皮肤病变的 miRNA 表达谱。
PLoS One. 2018 Aug 16;13(8):e0202579. doi: 10.1371/journal.pone.0202579. eCollection 2018.
4
Identification of A Panel of Serum microRNAs as Biomarkers for Early Detection of Lung Adenocarcinoma.一组血清微小RNA作为早期检测肺腺癌生物标志物的鉴定
J Cancer. 2017 Jan 1;8(1):48-56. doi: 10.7150/jca.16644. eCollection 2017.
5
MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.微小RNA-613通过调节鞘氨醇激酶2抑制甲状腺乳头状癌的细胞生长、迁移和侵袭。
Oncotarget. 2016 Jun 28;7(26):39907-39915. doi: 10.18632/oncotarget.9530.
6
miR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1.微小RNA-613通过靶向双皮质素样激酶1抑制人肝癌细胞的生长和侵袭能力。
Biochem Biophys Res Commun. 2016 May 13;473(4):987-992. doi: 10.1016/j.bbrc.2016.04.003. Epub 2016 Apr 2.
7
MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer.微小RNA-613通过靶向细胞周期蛋白依赖性激酶4诱导非小细胞肺癌细胞周期停滞。
Cell Oncol (Dordr). 2016 Apr;39(2):139-47. doi: 10.1007/s13402-015-0262-4. Epub 2016 Jan 7.
8
MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7.微小RNA-613通过靶向卷曲蛋白7抑制前列腺癌细胞的增殖和侵袭。
Biochem Biophys Res Commun. 2016 Jan 15;469(3):633-8. doi: 10.1016/j.bbrc.2015.12.054. Epub 2015 Dec 15.
9
MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.微小RNA-613通过调控KRAS抑制卵巢癌细胞的增殖和侵袭。
Tumour Biol. 2016 May;37(5):6477-83. doi: 10.1007/s13277-015-4507-7. Epub 2015 Dec 2.
10
MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.MiR-613:一种用于食管鳞状细胞癌患者的新型诊断和预后生物标志物。
Tumour Biol. 2016 Apr;37(4):4383-91. doi: 10.1007/s13277-015-4271-8. Epub 2015 Oct 24.